Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Abrams

Showing results (341-350 of 367) with videos related to

Pageof 37
Sort By:
Advances in Wound Care|January 25, 2021
Surgical Management of Lower Extremity Wounds in the Solid Organ Transplant Patient Population: Surgeon BewareAreeg A Abu El Hawa, Jenna C Bekeny, Paige K Dekker, et al.
Cells|April 30, 2021
GSK-3β Can Regulate the Sensitivity of MIA-PaCa-2 Pancreatic and MCF-7 Breast Cancer Cells to Chemotherapeutic Drugs, Targeted Therapeutics and NutraceuticalsStephen L Abrams, Shaw M Akula, Akshaya K Meher, et al.
Biochimica Et Biophysica Acta|November 28, 2006
Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistanceJames A McCubrey, Linda S Steelman, William H Chappell, et al.
Advances in Biological Regulation|February 28, 2018
Metformin influences drug sensitivity in pancreatic cancer cellsSaverio Candido, Stephen L Abrams, Linda Steelman, et al.
Advances in Biological Regulation|August 11, 2020
Cancer therapy and treatments during COVID-19 eraShaw M Akula, Stephen L Abrams, Linda S Steelman, et al.
Advances in Biological Regulation|October 27, 2018
Abilities of berberine and chemically modified berberines to inhibit proliferation of pancreatic cancer cellsStephen L Abrams, Matilde Y Follo, Linda S Steelman, et al.
Biochimica Et Biophysica Acta|September 11, 2016
Effects of mutations in Wnt/β-catenin, hedgehog, Notch and PI3K pathways on GSK-3 activity-Diverse effects on cell growth, metabolism and cancerJames A McCubrey, Dariusz Rakus, Agnieszka Gizak, et al.
Oncotarget|June 17, 2014
GSK-3 as potential target for therapeutic intervention in cancerJames A McCubrey, Linda S Steelman, Fred E Bertrand, et al.
Current Pharmaceutical Design|March 8, 2012
Targeting the cancer initiating cell: the ultimate target for cancer therapyJames A McCubrey, Linda S Steelman, Stephen L Abrams, et al.
Oncotarget|December 22, 2016
Roles of GSK-3 and microRNAs on epithelial mesenchymal transition and cancer stem cellsJames A McCubrey, Timothy L Fitzgerald, Li V Yang, et al.
Pageof 37

Showing results (341-350 of 367) with videos related to

Sort By:
Pageof 37
Advances in Wound Care|January 25, 2021
Surgical Management of Lower Extremity Wounds in the Solid Organ Transplant Patient Population: Surgeon BewareAreeg A Abu El Hawa, Jenna C Bekeny, Paige K Dekker, et al.
Cells|April 30, 2021
GSK-3β Can Regulate the Sensitivity of MIA-PaCa-2 Pancreatic and MCF-7 Breast Cancer Cells to Chemotherapeutic Drugs, Targeted Therapeutics and NutraceuticalsStephen L Abrams, Shaw M Akula, Akshaya K Meher, et al.
Biochimica Et Biophysica Acta|November 28, 2006
Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistanceJames A McCubrey, Linda S Steelman, William H Chappell, et al.
Advances in Biological Regulation|February 28, 2018
Metformin influences drug sensitivity in pancreatic cancer cellsSaverio Candido, Stephen L Abrams, Linda Steelman, et al.
Advances in Biological Regulation|August 11, 2020
Cancer therapy and treatments during COVID-19 eraShaw M Akula, Stephen L Abrams, Linda S Steelman, et al.
Advances in Biological Regulation|October 27, 2018
Abilities of berberine and chemically modified berberines to inhibit proliferation of pancreatic cancer cellsStephen L Abrams, Matilde Y Follo, Linda S Steelman, et al.
Biochimica Et Biophysica Acta|September 11, 2016
Effects of mutations in Wnt/β-catenin, hedgehog, Notch and PI3K pathways on GSK-3 activity-Diverse effects on cell growth, metabolism and cancerJames A McCubrey, Dariusz Rakus, Agnieszka Gizak, et al.
Oncotarget|June 17, 2014
GSK-3 as potential target for therapeutic intervention in cancerJames A McCubrey, Linda S Steelman, Fred E Bertrand, et al.
Current Pharmaceutical Design|March 8, 2012
Targeting the cancer initiating cell: the ultimate target for cancer therapyJames A McCubrey, Linda S Steelman, Stephen L Abrams, et al.
Oncotarget|December 22, 2016
Roles of GSK-3 and microRNAs on epithelial mesenchymal transition and cancer stem cellsJames A McCubrey, Timothy L Fitzgerald, Li V Yang, et al.
Pageof 37